Aktiebolaget Biopharmacon

ABActive

Org 5563302453Sveavägen 8, 752 36 UppsalaBusiness and other management consultancy activities · NACE 7020Est. 19881 employees

Overview Financials People & ownership Related companies

Aktiebolaget Biopharmacon is a Swedish AB based in Uppsala, operating in the Konsultverksamhet avseende företags organisation sector. Incorporated in 1988, the company has 1 employee and reported revenue of SEK 366K in its latest annual filing.

Revenue 2025

SEK 366K

-24% vs 2024

EBITDA margin

-14.4%

-185% vs 2024

Equity ratio

96.1%

Financial strength

Net profit 2025

SEK 229K

+73% vs 2024

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 366K	-24%
EBITDA	SEK -53K	-185%
Net profit	SEK 229K	+73%
Total assets	SEK 7M	-1%
Equity	SEK 6,8M	+4%
Employees	1	—

Contact

Address

Sveavägen 8, 752 36 Uppsala

Phone

+4618508470

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Aktiebolaget Biopharmacon?

Aktiebolaget Biopharmacon is registered with Bolagsverket / SCB under Org 5563302453.

What is the revenue of Aktiebolaget Biopharmacon?

Aktiebolaget Biopharmacon reported revenue of SEK 366K in 2025.

How many employees does Aktiebolaget Biopharmacon have?

Aktiebolaget Biopharmacon employs 1 people as of the latest annual report.

Who is the CEO of Aktiebolaget Biopharmacon?

Eva Maria Andersson Dverstorp is Audit of Aktiebolaget Biopharmacon, in role since 2021.

Who is the chairman of Aktiebolaget Biopharmacon?

Bengt Erik Dahlström chairs the board of Aktiebolaget Biopharmacon, in role since 2025.

Where is Aktiebolaget Biopharmacon headquartered?

Aktiebolaget Biopharmacon's registered address is Sveavägen 8.

Aktiebolaget Biopharmacon

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Aktiebolaget Biopharmacon

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Aktiebolaget Biopharmacon